XML 45 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments (Tables)
12 Months Ended
Jan. 02, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance
A summary of the company’s interest rate swaps is as follows (in thousands):
  Twelve Months Ended
 LocationJan 2, 2021Dec 28, 2019
Fair valueOther assets$— $1,830 
Fair valueAccrued expenses$14,075 $— 
Fair valueOther non-current liabilities$37,018 $25,120 
Amount of gain/(loss) recognized in other comprehensive incomeOther comprehensive income$(43,317)$(31,396)
Gain/(loss) reclassified from accumulated other comprehensive income (effective portion)Interest expense$(15,514)$1,256